A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus, EMBO J, vol.11, pp.527-562, 1992. ,
Mélanocytes épidermiques et mélanocytes folliculaires, Ann Genet Sél Anim, vol.13, issue.1, pp.17-26, 1981. ,
La biogenèse des mélanosomes : L'échiquier de la pigmentation, Med Sci, vol.27, issue.2, pp.153-162, 2011. ,
Making sense of melanosome dynamics in mouse melanocytes, Pigment Cell Res, vol.13, pp.241-247, 2000. ,
Peroxidase dependent oxidation of tyrosine to melanin in leucoderm vitiliginous skin, Indian J Med Res, vol.62, pp.1720-1724, 1974. ,
Biochemical and genetic studies of pigment type switching, Pigment Cell Res, vol.138, pp.48-53, 2000. ,
Tyrosinase: A comprehensive review of its mechanism, Biochim Biophys Acta, vol.131247, pp.1-11, 1995. ,
Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis, Embo J, vol.13, pp.5818-5843, 1994. ,
Dopa compared with dihydroxyfumarate as cofactor in peroxidase-mediated oxidation of tyrosine to melanin, Histochemie, vol.27, pp.331-334, 1971. ,
Peroxidase as an alternative to tyrosinase in the oxidative polymerization of 5,6-dihydroxyindoles to melanin(s), Biochim Biophys Acta, vol.161073, pp.423-430, 1991. ,
Melanocortin recepors: identification and characterization by melanotropic peptide agonists and antagonists, Pigment Cell Res, vol.9, pp.213-234, 1986. ,
Racial differences in the fate of melanosomes in human epidermis, Nature, vol.222, pp.1081-1082, 1969. ,
Albinism. In The Metabolic and Molecular bases of inherited Disease, pp.4353-4392 ,
Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism, J. Clin. Invest, vol.87, pp.1046-1053, 1991. ,
Mutation in and lack of expression of tyrosinase -related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism : a new subtype of albinism classified as «OCA 3», Am. J. Hum. Genet, vol.58, pp.1145-1156, 1996. ,
Mammalian Tyrosinase: Effect of Ions on Enzyme Action, Archives of Biochemistry and Biophysics, vol.36, issue.2, pp.473-481, 1951. ,
Mercury sensitisation: review, relevance and a clinical report, BDJ, vol.122, issue.7, pp.373-381, 2008. ,
DOI : 10.1038/sj.bdj.2008.843
Membranous nephropathy due to skin-lightening cream, BMJ, vol.2, pp.646-647, 1974. ,
Nephrotic Syndrome in Adult Africans in Nairobi, BMJ, vol.2, issue.5806, pp.131-135, 1972. ,
DOI : 10.1136/bmj.2.5806.131
Mechanism of depigmentation by hydroquinone, J Invest Dermatol, vol.62, issue.4, pp.436-485, 1974. ,
Skin depigmentation by hydroquinone: a chemical and biochemical insight, Pigment Cell Res, issue.2, pp.299-303, 1992. ,
The Toxicology of Hydroquinone ??? Relevance to Occupational and Environmental Exposure, Critical Reviews in Toxicology, vol.105, issue.3, pp.283-330, 1999. ,
DOI : 10.1016/0041-008X(79)90441-1
Topical hydroquinone in the treatment of some hyperpigmentary disorders, Int J Dermatol, vol.37, issue.6, pp.449-50, 1998. ,
Community-based trial of a triple-combination agent for the treatment of facial melasma, Cutis, vol.77, issue.3, pp.177-84, 2006. ,
Retinoic Acid is a Potent Inhibitor of Inducible Pigmentation in Murine and Hamster Melanoma Cell Lines, Journal of Investigative Dermatology, vol.94, issue.4, pp.461-464, 1990. ,
DOI : 10.1111/1523-1747.ep12874568
Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial, British Journal of Dermatology, vol.7, issue.4, pp.415-436, 1993. ,
DOI : 10.1111/1523-1747.ep12874568
Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial, Archives of Dermatology, vol.130, issue.6, pp.727-760, 1994. ,
DOI : 10.1001/archderm.130.6.727
AZELAIC ACID: PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES AND ITS THERAPEUTIC ROLE IN HYPERPIGMENTARY DISORDERS AND ACNE, International Journal of Dermatology, vol.1, issue.2, pp.75-84, 1995. ,
DOI : 10.1111/1523-1747.ep12276684
Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases, Archives of Dermatological Research, vol.225, issue.3, pp.162-166, 1991. ,
DOI : 10.1007/BF00372056
Azelaic acid (15% gel) in the treatment of acne rosacea, International Journal of Dermatology, vol.74, issue.5, pp.533-541, 2007. ,
DOI : 10.1111/j.1468-3083.2005.01216.x
The treatment of melasma 20% azelaic acid versus 4% hydroquinone cream ,
Mechanism of free radical formation and disappearance during the ascorbic acid oxidase and peroxidase reactions, Biochimica et Biophysica Acta, vol.50, issue.1, pp.62-962, 1961. ,
DOI : 10.1016/0006-3002(61)91060-5
Human dermal fibroblasts in monolayer tissue culture. Effect of ascorbic acid analogues, J Lab Clin Med, vol.66, issue.4, pp.659-66, 1965. ,
The effects of glutathione and ascorbic acid on the oxidations of 6-hydroxydopa and 6-hydroxydopamine, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1201, issue.3, pp.498-504, 1994. ,
DOI : 10.1016/0304-4165(94)90082-5
Inhibitory effect of magnesium l-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo, Journal of the American Academy of Dermatology, vol.34, issue.1, pp.29-33, 1996. ,
DOI : 10.1016/S0190-9622(96)90830-0
The inhibitory effect of glycolic acid and lactic acid on melanin synthesis in melanoma cells, Experimental Dermatology, vol.106, issue.s2, pp.43-50, 2003. ,
DOI : 10.1111/1523-1747.ep12392743
Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma, International Journal of Dermatology, vol.157, issue.12, pp.42966-72, 2003. ,
DOI : 10.1046/j.1524-4725.2002.01129.x
The Merck Index, NJ, p.1058, 1976. ,
Inhibitory Effects of 4-n-Butylresorcinol on Tyrosinase Activity and Melanin Synthesis, Biol. Pharm. Bull, vol.28, issue.12, pp.2216-2219, 2005. ,
Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial, British Journal of Dermatology, vol.61, issue.5, pp.997-1004, 2007. ,
DOI : 10.1080/09546630050517333
-butylresorcinol 0.1% cream for the treatment of melasma: A randomized controlled split-face trial, The Journal of Dermatology, vol.19, issue.4, pp.311-316, 2010. ,
DOI : 10.1111/j.1346-8138.2010.00787.x
The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer, British Journal of Dermatology, vol.326, issue.1, pp.20-31, 2002. ,
DOI : 10.1046/j.1523-1747.2000.00035.x
Pharmacologic doses of nicotinamide en the treatment of inflammatory skin conditions: a review, Cutis, vol.77, issue.1, pp.11-17, 2006. ,
Delivering actives at the SCC Technology showcase. Cosmetics and toilleteries, pp.18-21, 2004. ,
Use of compounds that inactivates protein kinase A in a composition containing a cosmetically acceptable medium for lightening the skin, Patent, vol.871, issue.7, p.635, 2011. ,
A lotion containing undecylenoyl phenylalanine and ergothioneine reduces melanin levels without affecting tissue viability in artificial skin constructs, J Am Acad Dermatol, vol.60, p.79, 2009. ,
-undecyl-10-enoyl-l-phenylalanine and its combination with niacinamide, Journal of Cosmetic Dermatology, vol.17, issue.4, pp.260-266, 2009. ,
DOI : 10.1111/j.1473-2165.2009.00470.x
A randomized, double-blind, vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines, Clinical and Experimental Dermatology, vol.138, issue.Suppl. 37 ,
DOI : 10.1111/j.1365-2230.2009.03605.x
Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives, British Journal of Dermatology, vol.50, issue.Suppl. 2, pp.1267-1274, 2008. ,
DOI : 10.1111/j.1365-2133.2008.08864.x
DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency, Experimental Dermatology, vol.29, issue.8, pp.601-608, 2005. ,
DOI : 10.1016/0165-1161(75)90046-1
DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency, Experimental Dermatology, vol.29, issue.8, pp.601-609, 2005. ,
DOI : 10.1016/0165-1161(75)90046-1
Kojic acid, a cosmetic skin whitening agent, is a slowbinding inhibitor of catecholase activity of tyrosinase, J Pharm Pharmacol, vol.46, issue.12, pp.982-987, 1994. ,
Hyperpigmentation: An overview of the common afflictions ,
Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors, Biochem Pharmacol, vol.57, issue.6, p.6, 1999. ,
Effects of 3-isobutyl-1-methylxanthine and kojic acid on cocultures and skin equivalents composed of HaCaT cells and human melanocytes, Archives of Dermatological Research, vol.295, issue.2, pp.88-91, 2003. ,
DOI : 10.1007/s00403-003-0401-z
The Inhibitory Effect of Glabridin from Licorice Extracts on Melanogenesis and Inflammation, Pigment Cell Research, vol.17, issue.6, pp.355-61, 1998. ,
DOI : 10.1111/1523-1747.ep12462151
The Use of Botanical Extracts as Topical Skin-Lightening Agents for the Improvement of Skin Pigmentation Disorders, Journal of Investigative Dermatology Symposium Proceedings, vol.13, issue.1, pp.20-24, 2008. ,
DOI : 10.1038/jidsymp.2008.8
Mechanisms of UV-induced inflammation, J Invest Dermatol, vol.100, pp.35-41, 1993. ,
Topical liquiritin improves melasma, Int J Dermatol, vol.39, issue.4, pp.299-301, 2000. ,
Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma, An Bras Dermatol, 2010. ,
Melasma: A clinical, light microscopic, ultrastructural, and immunofluorescence study, Journal of the American Academy of Dermatology, vol.4, issue.6, pp.698-710, 1981. ,
DOI : 10.1016/S0190-9622(81)70071-9
Melasma: Classification and treatment, J Eur Acad Dermatol Venereol, vol.4, pp.217-240, 1995. ,
An epidemiologic survey on the cosmetic use of bleaching agents by the women of Bamako, Mali, Ann dermatol venereol, vol.120, pp.870-873, 1993. ,
La d??pigmentation volontaire, L'Autre, vol.8, issue.1, 2005. ,
DOI : 10.3917/lautr.022.0095
Prevalence of use of skin bleaching cosmetics in two areas in Dakar, Sénégal, Dakar Med, vol.45, pp.154-161, 2000. ,
Pratique de la dépigmentation artificielle de la peau chez les femmes à Dakar et étude analytique des produits dits cosmétiques utilisés, Dakar Med, vol.39, pp.223-229, 1994. ,
L'usage cosmétique des produits dépigmentants en Afrique, Bull Soc Path Exo, vol.96, pp.389-93, 2003. ,
Use of cutaneous depigmenting products by women in two towns in Burkina Faso: epidemiologic data, motivations, products and side effects, International Journal of Dermatology, vol.128, issue.s1 ,
DOI : 10.1111/j.1365-4632.2005.02807.x
Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal, Br J Dermatol, vol.148, issue.3, pp.493-500, 2003. ,
Enquête qualitative sur la dépigmentation artificielle de la peau noire : essai d'analyse anthropologique et psychosociale en contexte sénégalais, Ann Dermatol Venereol, vol.134, issue.1, pp.21-23, 2007. ,
Tropical steroid abuse: its use as a depigmenting agent, J Natl Med Assoc, vol.98, pp.934-943, 2006. ,
Les pratiques cosmétiques dépigmentantes des femmes a Lomé (TOGO).Méd Afr Noire, pp.709-713, 1998. ,
Les accidents des pratiques de dépigmentation cutanée cosmétique chez la femme africaine, Bull Soc Med Afr Lang Fr, vol.21, pp.190-199, 1976. ,
Complication de la dépigmentation cosmétique en Afrique, Med. Trop, pp.627-660, 2007. ,
Prenatal and Early Postnatal Intoxication by Inorganic Mercury Resulting from the Maternal Use of Mercury Containing Soap, Human & Experimental Toxicology, vol.6, issue.3, pp.253-259, 1987. ,
DOI : 10.1177/096032718700600316
Dépigmentation cutanée à visée cosmétique : Enquête de prévalence et effets indésirables dans une population féminine Sénégalaise, Ann Dermatol Venereol, vol.128, pp.720-724, 2001. ,
Adverse effects of topical glucocorticosteroids, J Am Acad Dermatol, vol.54, pp.1-15, 2006. ,
Leucomélanodermies accidentelles provoquées par les topiques dépigmentants, Annal. Dermatol. Vénéréol, issue.8, pp.109641-109648, 1982. ,
Leucomelanoderma in blacks. A recent epidemic, S. Afr. Med. J, vol.48, pp.1555-1563, 1974. ,
Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams, Br J Dermatol, vol.93, pp.613-635, 1975. ,
Complications néphrologiques et cutanées secondaires à l'utilisation de produits dépigmentants, Nouv. Dermatol, vol.17, pp.644-650, 1998. ,
Freinage hypothalamo-hypophyso-surrénalien lié à l'usage des cosmétiques dépigmentants au Sénégal, Bull. Soc. Pathol. Exot, vol.94, pp.249-52, 2001. ,
Skin lightening and its complications in the African population of Paris. Communication au congrès de l'international Association for Cosmetic Dermatology, 2005. ,